Additional file 2 of GC–IMS facilitates identification of carbapenem-resistant Klebsiella pneumoniae in simulated blood cultures

Additional file 2: Table S2. Temporal changes in VOCs measured by GC–IMS (without imipenem added, standard strains). Table S3. The change of VOCS in T2 time period compared with the blank control group (without imipenem added, standard strains, mean ± SD). Table S4. Temporal changes in VOCs measured by GC–IMS (with imipenem added, standard strains). Table S5. The change of VOCs in T2 time point compared with the CSKP group (with imipenem added, standard strains, mean ± SD). Table S6. The change of VOCs in T2 time point after adding enzyme inhibitors treatment (realtive volume of VOC, mean ± SD, standard strains). Table S7. The change of VOCS in T2 time point compared with the CSKP group (with imipenem added, clinical isolates, mean ± SD). Table S8. The change of VOCs in T2 time point after adding enzyme inhibitors treatment (realtive volume of VOC, mean ± SD, clinical isolates).

附加文件2：表S2。采用气相色谱-离子迁移谱（Gas Chromatography-Ion Mobility Spectrometry, GC–IMS）测定的挥发性有机化合物（Volatile Organic Compounds, VOCs）的时间变化规律（未添加亚胺培南，标准菌株）。表S3。与空白对照组相比，T2时间段内挥发性有机化合物的变化情况（未添加亚胺培南，标准菌株，均值±标准差（Standard Deviation, SD））。表S4。采用气相色谱-离子迁移谱（GC–IMS）测定的挥发性有机化合物的时间变化规律（添加亚胺培南，标准菌株）。表S5。与CSKP组相比，T2时间点的挥发性有机化合物变化情况（添加亚胺培南，标准菌株，均值±标准差）。表S6。经酶抑制剂处理后T2时间点的挥发性有机化合物变化情况（挥发性有机化合物相对含量，均值±标准差，标准菌株）。表S7。与CSKP组相比，T2时间点的挥发性有机化合物变化情况（添加亚胺培南，临床分离株，均值±标准差）。表S8。经酶抑制剂处理后T2时间点的挥发性有机化合物变化情况（挥发性有机化合物相对含量，均值±标准差，临床分离株）。